The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Independent advisers to the FDA voted against recommending Lexicon Pharmaceuticals‘ add-on treatment to insulin therapy for ...

In a sample of 100 hospitals, 34 didn’t meet requirements for publishing machine-readable files of their charges while 14 ...

Oracle Health’s next-generation EHR is not just designed to be a scribe or an assistant. But rather a doctor’s best resident, ...

Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US. The FDA sent the Danish ...

CVS Health (NYSE:CVS) just rocked the market with a nearly 11% surge in pre-market trading after its Q3 revenue topped expectations, hitting a staggering $95.4 billion. This beat, the first of ...

CVS Health reported better-than-expected quarterly results, and the new CEO made executive changes. The news lifted the stock Wednesday. Revenue was lifted by jumps in sales at the firm's Pharmacy ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...

(AP) — CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under new CEO David Joyner after a rough year that has sent ...